当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 资产负债表

康泰医学

(300869)

  

流通市值:41.77亿  总市值:67.02亿
流通股本:2.50亿   总股本:4.02亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金362,964,487.151,193,844,218.781,127,658,903.271,392,695,435.4
应收票据及应收账款52,088,842.2363,180,465.91170,297,429.77160,752,363.98
其中:应收票据1,207,5008,452,5008,560,500-
应收账款50,881,342.2354,727,965.91161,736,929.77160,752,363.98
预付款项12,273,278.6310,142,662.3813,545,513.126,642,946.42
其他应收款合计10,893,608.5411,319,934.927,929,299.9713,764,814.45
其中:应收利息-1,367,351.61-504.95
存货510,787,631.05520,630,299.52514,444,464.13430,236,285.05
一年内到期的非流动资产935,713,097.26927,367,563.01964,080,834.59486,265,200.34
其他流动资产101,288,280.7101,296,534.54121,171,519.511,422,396.3
流动资产平衡项目0000
流动资产合计2,636,067,417.342,847,788,363.992,943,249,312.272,558,415,892.24
非流动资产:
投资性房地产17,943,276.3618,326,803.7118,710,331.0619,093,858.41
固定资产270,211,824.39272,898,628.28272,562,633.98267,898,744.46
在建工程16,485,877.93,138,878.742,185,948.711,324,446.4
使用权资产4,466,713.564,922,770.175,417,104.485,911,438.79
无形资产55,411,465.4256,095,888.1356,785,028.6957,474,169.4
递延所得税资产1,360,792.341,416,728.41,382,312.721,808,915.66
其他非流动资产464,284,446.43460,614,188.98386,291,386.73820,878,367.09
非流动资产平衡项目0000
非流动资产合计830,164,396.4817,413,886.41743,334,746.371,174,389,940.21
资产平衡项目0000
资产总计3,466,231,813.743,665,202,250.43,686,584,058.643,732,805,832.45
流动负债:
短期借款562,878,400762,878,400.16690,275,645.86903,373,608.68
应付票据及应付账款22,705,048.4530,067,291.3475,505,263.3854,302,076.3
应付账款22,705,048.4530,067,291.3475,505,263.3854,302,076.3
合同负债44,329,845.7245,325,434.3640,406,666.8876,603,803.81
应付职工薪酬12,043,732.0512,131,516.613,192,481.6415,121,091.96
应交税费38,401,342.6841,966,912.3860,207,358.7835,600,531.34
其他应付款合计10,380,117.412,588,266.715,341,644.6225,889,097.55
一年内到期的非流动负债1,513,620.711,508,472.981,581,886.631,667,981.74
流动负债平衡项目0000
流动负债合计692,252,107.01906,466,294.52896,510,947.791,112,558,191.38
非流动负债:
应付债券687,488,629.32682,285,669.01672,437,417.39666,939,473.8
租赁负债2,870,380.533,301,909.783,721,940.854,056,446.71
递延收益8,005,572.878,492,521.098,979,469.319,066,822.73
递延所得税负债896,981.771,876,236.297,038,827.0411,851,068.57
非流动负债平衡项目0000
非流动负债合计699,261,564.49695,956,336.17692,177,654.59691,913,811.81
负债平衡项目0000
负债合计1,391,513,671.51,602,422,630.691,588,688,602.381,804,472,003.19
所有者权益(或股东权益):
实收资本(或股本)401,802,671401,802,664401,799,372401,796,800
其他权益工具29,464,357.2629,464,548.2429,554,031.1529,623,192.7
资本公积345,292,999.08345,291,620.16345,116,955.63344,981,225.71
其他综合收益3,500,007.213,793,800.671,608,245.942,167,811.33
盈余公积157,530,943.3157,530,943.3157,530,943.3157,530,943.3
未分配利润1,137,127,164.391,124,896,043.341,162,285,908.24992,233,856.22
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,074,718,142.242,062,779,619.712,097,895,456.261,928,333,829.26
股东权益平衡项目0000
股东权益合计2,074,718,142.242,062,779,619.712,097,895,456.261,928,333,829.26
负债和股东权益合计3,466,231,813.743,665,202,250.43,686,584,058.643,732,805,832.45
公告日期2023-10-302023-08-302023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑